Damora Therapeutics grants options for 144,400 shares to new hires at $21.28 exercise price
DMRA•Damora Therapeutics granted options covering 144,400 shares to five newly hired non-executive employees, with an exercise price of $21.28 per share.
1. Option award terms
The options have a 10-year term and were issued on Oct. 1, 2026, under the company’s 2022 Inducement Plan. Vesting begins with 25% on each employee’s first anniversary, followed by monthly installments over 36 months.
